# Gender-Sensitive Depression Scales: A Review of Male-Specific Assessment Tools

**Authors:** Dominika Jabłonka, Maja Łądkowska, Natalia Kossak, Stefan Modzelewski, Napoleon Waszkiewicz

PMC · DOI: 10.3390/diagnostics16060925 · 2026-03-20

## TL;DR

This paper reviews depression scales designed for men, which may better capture their unique symptoms and help reduce suicide rates.

## Contribution

The paper provides a narrative review of male-specific depression scales and their potential clinical utility.

## Key findings

- Male-sensitive scales capture symptoms like emotional suppression, anger, and risk-taking behaviors.
- The MDRS-22 and MDRS-7 are sensitive to externalizing symptoms linked to male depression and suicide risk.
- Current evidence is limited by non-clinical samples and lack of cross-cultural validation.

## Abstract

Background: Depression in men often goes unrecognized, even though it leads to high rates of suicide. Men may show symptoms that are external, behavioral, or physical, which traditional assessment tools focused on internal symptoms do not adequately reflect. Methods: A narrative review was carried out to gather evidence on depression scales tailored for men. We searched PubMed up to November 2025 for studies discussing the development, validation, and clinical use of the Gotland Male Depression Scale (GMDS), the Male Depression Risk Scale (MDRS-22 and MDRS-7), and the Gender-Sensitive Depression Screening scale (GSDS-26). We organized the findings by instrument. Results: The studies indicate that male-sensitive scales capture symptom domains such as emotional suppression, anger, risk-taking behaviors, substance misuse, and somatic complaints. The GMDS has demonstrated applicability across psychiatric, somatic, and paternal perinatal populations. The MDRS-22 and MDRS-7 were particularly sensitive to externalizing symptom patterns associated with male presentations of depression and behavioral profiles linked to elevated suicide risk. The GSDS-26 integrates both prototypical and externalizing symptoms, enabling the identification of diverse depressive profiles. However, the current evidence base remains limited due to a reliance on non-clinical samples and the scarcity of long-term and cross-cultural validation studies. Conclusions: Male-sensitive depression scales may serve as useful complementary screening tools that improve recognition of male-typical depressive presentations and behavioral patterns associated with increased suicide risk. Further clinical and longitudinal research is needed to confirm their diagnostic accuracy and clinical utility.

## Linked entities

- **Diseases:** depression (MONDO:0002050)

## Full-text entities

- **Diseases:** psychiatric (MESH:D001523), Depression (MESH:D003866), substance misuse (MESH:D009293), externalizing symptoms (MESH:D012816)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC13024911